News Detail
New Delhi, 11 Feb 2025: The National Pharmaceutical Pricing Authority (NPPA) has fixed the retail prices of 42 new drugs under the Drugs Prices Control Order (DPCO), 2013 revised the ceiling prices of two formulations based on review orders from the Department of Pharmaceuticals ......
View Details
Source : Pharmabiz
National Pharmaceutical Pricing Authority
NPPA
retail prices
Drugs Prices Control Order
DPCO 2013
DoP
typographical error
Cipla
sitagliptin
dapagliflozin
glimepiride
metformin hydrochloride
empagliflozin
talmisartan
cilnidipine
chlorthalidone
atorvastatin
ezetimibe
Cadila
Diclofenac
paracetamol
chlorzoxazone
Macleods Pharmaceuticals
Bictegravir
emtricitabine
tenofovir alafenamide
Cipla
Related News
- DCGI calls for focused interventions to enhance drug quality (11-02-2025)
- NPPA asks retailers, dealers and online pharmacies to ensure compliance of Para 24 and 25 of DPCO, 2013 (11-02-2025)
- Kerala: 12 establishments caught selling fake cosmetics, including soaps and creams, with harmful chemicals (11-02-2025)
- EMA establishes regular procedure for scientific advice on certain high-risk medical devices (11-02-2025)
- Goyal urges the pharmaceutical industry to expose those engaged in sale of counterfeit products (11-02-2025)
- WHO identifies research priorities for boosting fight against antimicrobial resistance (11-02-2025)
- Supreme Court Calls on State Officials to Address Misleading Drug Advertisements (10-02-2025)
- Cases will be initiated immediately against individuals involved in sale of intoxicants and adulteration of drugs (10-02-2025)
- An index to gauge states for drug enforcement, improve drug quality (10-02-2025)
- China's health regulator defends quality of local generic drugs (10-02-2025)